Application of super-resolution microscopic imaging in pathological diagnosis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100047756

Enrollment

Unknown

Registered

2021-06-26

Start date

2021-07-26

Completion date

Unknown

Last updated

2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma

Interventions

Gold Standard:Fluorescence in situ hybridization and fluorescence microscopy.

Index test:1p19q&#32

codeletion,&#32

EGFR&#32

amplification,CDKN2A&#32

mutation,7gain/10loss,HOXA5&#32

amplification.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria More than 2 pathologists re-read the pictures together and confirmed the diagnosis as high-grade glioma.

Exclusion criteria

Exclusion criteria: No.

Design outcomes

Primary

Measure	Time frame
the super-resolution imaging of subcellular structures;Super-resolution imaging of key molecules;	—

Countries

China

Contacts

Public ContactPing Yifang

The frist Affiliated Hospital of Army Medical University, PLA

pingyifang@126.com+86 18623448461

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026